Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp.

Journal of Clinical Microbiology

Volumn 44, Issue 11, 2006, Pages 4072-4076

  O'Sullivan, Matthew V N ^a,d   Cai, Yongwei ^a,b   Kong, Fanrong ^a   Zeng, Xianyu ^a,c   Gilbert, Gwendolyn L ^a  

^a Western Sydney Area Health Service   (Australia)

^b Third People's Hospital of Hangzhou   (China)

^c Wuhan First Hospital   (China)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CLINDAMYCIN; COAGULASE; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; D TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISK APPROXIMATION TEST; DISK SEPARATION DISTANCE; FALSE NEGATIVE RESULT; GEOGRAPHIC DISTRIBUTION; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; GENOTYPE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 33750934941     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01632-06     Document Type: Article

References (38)

1. Chavez-Bueno, S., B. Bozdogan, K. Katz, K. L. Bowlware, N. Cushion, D. Cavuoti, N. Ahmad, G. H. McCracken, Jr., and P. C. Appelbaum. 2005. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob. Agents Chemother. 49:2283-2288.
2. Clinical and Laboratory Standards Institute. 2003. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8 (ISBN 1-56238-485-6), 8th ed. Clinical and Laboratory Standards Institute, Wayne, Pa.
3. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth international supplement M100-S15, p. 44-51. Clinical and Laboratory Standards Institute, Wayne, Pa.
4. Delialioglu, N., G. Aslan, C. Ozturk, V. Baki, S. Sen, and G. Emekdas. 2005. Inducible clindamycin resistance in staphylococci isolated from clinical samples. Jpn. J. Infect. Dis. 58:104-106.
5. Drinkovic, D., E. R. Fuller, K. P. Shore, D. J. Holland, and R. Ellis-Pegler. 2001. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J. Antimicrob. Chemother. 48:315-316.
6. Eady, E. A., J. I. Ross, J. L. Tipper, C. E. Walters, J. H. Cove, and W. C. Noble. 1993. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother. 31:211-217.
7. Fiebelkorn, K. R., S. A. Crawford, M. L. McElmeel, and J. H. Jorgensen. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41:4740-4744.
8. Fokas, S., M. Tsironi, M. Kalkani, and M. Dionysopouloy. 2005. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin. Microbiol. Infect. 11:337-340.
9. Frank, A. L., J. F. Marcinak, P. D. Mangat, J. T. Tjhio, S. Kelkar, P. C. Schreckenberger, and J. P. Quinn. 2002. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21:530-534.
10. Gadepalli, R., B. Dhawan, S. Mohanty, A. Kapil, B. K. Das, and R. Chaudhry. 2006. Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus. Indian J. Med. Res. 123:571-573.
11. Hamilton-Miller, J. M., and S. Shah. 2000. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J. Antimicrob. Chemother. 46:941-949.
12. Hindler, J. F., and S. Munro. 2004. Evaluating antimicrobial susceptibility test systems, p. 5.17.1-5.17.11. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 2. ASM Press, Washington, D.C.
13. Jenssen, W. D., S. Thakker-Varia, D. T. Dubin, and M. P. Weinstein. 1987. Prevalence of macrolides-lincosamides-streptogramin B (sic) resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob. Agents Chemother. 31:883-888.
14. Kader, A. A., A. Kumar, and A. Krishna. 2005. Induction of clindamycin resistance in erythromycin-resistant, clindamycin susceptible and methicillin-resistant clinical staphylococcal isolates. Saudi Med. J. 26:1914-1917.
15. Kim, H. B., B. Lee, H. C. Jang, S. H. Kim, C. I. Kang, Y. J. Choi, S. W. Park, B. S. Kim, E. C. Kim, M. D. Oh, and K. W. Choe. 2004. A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea. Microb. Drug Resist. 10:248-254.
16. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
17. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
18. Levin, T. P., B. Suh, P. Axelrod, A. L. Truant, and T. Fekete. 2005. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob. Agents Chemother. 49:1222-1224.
19. Lim, J. A., A. R. Kwon, S. K. Kim, Y. Chong, K. Lee, and E. C. Choi. 2002. Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in gram-positive cocci isolated in a Korean hospital. J. Antimicrob. Chemother. 49:489-495.
20. Marr, J. K., A. T. Lim, and L. G. Yamamoto. 2005. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus. Hawaii Med. J. 64:6-8.
21. Matsuoka, M., K. Endou, H. Kobayashi, M. Inoue, and Y. Nakajima. 1998. A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol. Lett. 167:221-227.
22. Navaneeth, B. V. 2006. A preliminary in vitro study on inducible and constitutive clindamycin resistance in Staphylococcus aureus from a south Indian tertiary care hospital. Int. J. Infect. Dis. 10:184-185.
23. Panagea, S., J. D. Perry, and F. K. Gould. 1999. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J. Antimicrob Chemother. 44:581-582.
24. Patel, M., K. B. Waites, S. A. Moser, G. A. Cloud, and C. J. Hoesley. 2006. Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates. J. Clin. Microbiol. 44:2481-2484.
25. Pimentel, J. D., and G. D. Lum. 2006. Use of the D-test to determine the prevalence of inducible clindamycin-resistant Staphylococcus aureus in a Northern Territory hospital. Pathology 38:258-259.
26. Prunier, A. L., B. Malbruny, D. Tande, B. Picard, and R. Leclercq. 2002. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob. Agents Chemother. 46:3054-3056.
27. Rayner, C., and W. J. Munckhof. 2005. Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Intern. Med. J. 35(Suppl. 2):S3-S16.
28. Sanchez, M. L., K. K. Flint, and R. N. Jones. 1993. Occurrence of macrolide-lineosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem? Diagn. Microbiol. Infect. Dis. 16:205-213.
29. Sattler, C. A., E. O. Mason, Jr., and S. L. Kaplan. 2002. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr. Infect. Dis. J. 21:910-917.
30. Schmitz, F. J., J. Petridou, A. C. Fluit, U. Hadding, G. Peters, and C. von Eiff. 2000. Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. Multicentre Study on Antibiotic Resistance in Staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 19:385-387.
31. Schreckenberger, P. C., E. Ilendo, and K. L. Ristow. 2004. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J. Clin. Microbiol. 42:2777-2779.
32. Siberry, G. K., T. Tekle, K. Carroll, and J. Dick. 2003. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 37:1257-1260.
33. Spiliopoulou, I., E. Petinaki, P. Papandreou, and G. Dimitracopoulos. 2004. erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece. J. Antimicrob. Chemother. 53:814-817.
34. Steward, C. D., P. M. Raney, A. K. Morrell, P. P. Williams, L. K. McDougal, L. Jevitt, J. E. McGowan, Jr., and F. C. Tenover. 2005. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J. Clin. Microbiol. 43:1716-1721.
35. Werckenthin, C., S. Schwarz, and H. Westh. 1999. Structural alterations in the translational attenuator of constitutively expressed ermC genes. Antimicrob. Agents Chemother. 43:1681-1685.
36. Wondrack, L., M. Massa, B. V. Yang, and J. Sutcliffe. 1996. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob. Agents Chemother. 40:992-098.
37. York, M. K., M. M. Traylor, J. Hardy, and M. Henry. 2004. Coagulase test-rapid plasma method, p. 3.17.14.1-3.17.14.3. In H. D. Isenberg (ed.). Clinical microbiology procedures handbook, vol. I. ASM Press, Washington, D.C.
38. Zeng, X., F. Kong, H. Wang, A. Darbar, and G. L. Gilbert. 2006. Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob. Agents Chemother. 50:204-209.